Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.6160
H.R.6160: Access to Rare Indications Act of 2021
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced Dec. 7, 2021
- Latest Major Action Dec. 8, 2021
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
7 (4 Democrats, 3 Republicans)
Bill Version
- Introduced in House - Dec. 7, 2021
Bill Summary
Access to Rare Indications Act of 2021 This bill provides for coverage under the Medicare prescription drug benefit, Medicaid, and private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals). Such drugs must be supported by peer-reviewed research or medical experts and must not have been reviewed unfavorably in specified compendia or used...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Dec. 8, 2021 |
Referred to the Subcommittee on Health.
|
Dec. 7, 2021 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
Dec. 7, 2021 |
Introduced in the House by Doris Matsui (D-Calif.) |